The Venus P-Valve was the first pulmonary valve launched in Europe. Its self-expanding nitinol stent is the ideal solution for treating all sizes of ventricular tachycardia (RVOT). It aims to replace the pulmonary heart valve with an artificial valve using a minimally invasive percutaneous approach.

6 radiopaque markers;
Strong anchoring capacity;
Self-expanding valve;
Wide coverage of different valve sizes